EGASHIRA KENSUKE has a total of 18 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States, Japan and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are CUTANEA LIFE SCIENCES INC, NOVOVASCULAR INC and JOHNSON & JOHNSON REGENERATIVE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Japan | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Object sterilising | |
#4 | Peptides | |
#5 | Implantable devices |
# | Name | Total Patents |
---|---|---|
#1 | Egashira Kensuke | 17 |
#2 | Takeshita Akira | 6 |
#3 | Sata Masataka | 3 |
#4 | Masamichi Koyanagi | 1 |
#5 | Hara Kaori | 1 |
#6 | Tsukada Yusuke | 1 |
#7 | Kensuke Egashira | 1 |
#8 | Koyanagi Masamichi | 1 |
#9 | Nishida Ken-Ichi | 1 |
#10 | Bando Yohei | 1 |
Publication | Filing date | Title |
---|---|---|
JP2014196281A | Pharmaceutical composition | |
US2010331373A1 | Drug-containing nanoparticles | |
WO2005089822A1 | Medicine/gene leaching type stent | |
JP2004307427A | Therapeutic/improving/preventing agent for renal ischemia reperfusion injury | |
JP2003201253A | Prophylactic and/or therapeutic agent for post- transplant arteriosclerosis as rejection of organ transplant | |
WO03037376A1 | Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant | |
CN1469756A | Novel drugs for liver diseases | |
JP2002047203A | Prophylactic and therapeutic agent for pulmonary hypertension | |
JP2002284698A | Preventive and/or curative for vascular restenosis |